- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07756177
Guangzhou Preterm and Term Birth Cohort Study (GPTBC)
The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a prospective observational study of how early-life nutrition, environmental exposures, and family factors relate to the health and development of preterm and term infants and their mothers. Mother-infant pairs are followed from birth to 24 months. Researchers use questionnaires and biological samples to study human milk, microorganisms in the infant gut, physical growth, development, and allergic diseases, and whether these relationships differ between preterm and term infants. Findings may inform nutrition and health strategies for infants born at different gestational ages.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a single-center, prospective longitudinal observational study conducted at the Third Affiliated Hospital of Guangzhou Medical University. Mothers and their preterm or term infants were enrolled within 7 days after delivery and are followed primarily through 24 months of age; a subset receives additional follow-up beyond 24 months. The cohort was designed to recruit approximately equal numbers of preterm and term infants to characterize early-life exposures and health trajectories and to assess whether preterm birth modifies exposure-outcome associations.
The primary scientific focus is how human milk composition and other early-life nutritional and environmental exposures relate to infant growth, neuropsychological development, allergic diseases, and gut microbiome development. Serial human milk samples support measurements of nutritional components, 23 targeted human milk oligosaccharides, selected bioactive proteins, fatty acids, metabolomic and lipidomic profiles, microbial metagenomes, and exposomic profiles of environmental contaminants. Infant stool samples are analyzed using metagenomic sequencing. Additional stored biospecimens support related current and future research.
Repeated questionnaires capture maternal postpartum health, diet, lifestyle, psychological status, medication use, and breastfeeding; infant feeding, supplementation, illness, medication use, sleep, activity, screen exposure, and caregiving environment; and selected paternal and family characteristics. Child health is assessed longitudinally using anthropometry, standardized developmental assessments, eye tracking, parental reports of physician-diagnosed allergic diseases, and microbiome measures.
The study will examine exposure patterns and their changes over time, associations with maternal and child health, potential biological pathways, and differences between preterm and term infants.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Lieux d'étude
-
-
Guangdong
-
Guangzhou, Guangdong, Chine, 510000
- Sun Yat-sen University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Mother-infant pairs (term and preterm).
La description
Inclusion Criteria:
- Maternal age between 18 and 45 years.
- Resident in Guangzhou for at least one year.
- Gestational age at delivery ≥ 32 weeks and < 42 weeks (moderate-to-late preterm or term births).
Exclusion Criteria:
- Critical illness during pregnancy requiring admission to the intensive care unit.
- Unwilling or unable to breastfeed.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: PROSPECTIVE
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Preterm Birth Group
Mother-infant pairs in which the infant was born at 32 weeks 0 days to 36 weeks 6 days of gestation. |
This cohort study have any no intervention. |
|
Term Birth Group
Mother-infant pairs in which the infant was born at 37 weeks 0 days to 41 weeks 6 days of gestation. |
This cohort study have any no intervention. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Offspring Length/Height (cm)
Délai: Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
|
Offspring length or height measured by a pediatrician. |
Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
|
|
Offspring Weight (kg)
Délai: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Offspring weight measured using a calibrated scale. |
Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
|
Offspring Head Circumference (cm)
Délai: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Offspring head circumference measured by a pediatrician. |
Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
|
Offspring Body Mass Index (kg/m²)
Délai: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Calculated as weight (kg) divided by the square of length or height (in meters). |
Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
|
Neurodevelopmental outcome - Gesell Developmental Schedules (GDS)
Délai: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
|
Developmental Quotients (DQ) for each developmental domain, assessed by the Gesell Developmental Schedules (GDS) administered by a pediatrician. DQ is calculated as (developmental age / chronological age or corrected age) × 100, with higher DQ indicating better development. Domains include: (1) adaptive, (2) gross motor, (3) fine motor, (4) language, and (5) personal-social. |
1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
|
|
Neurodevelopmental outcome - Ages and Stages Questionnaires (ASQ)
Délai: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Parent-reported scores (0-60) for each developmental domain, assessed using the Ages and Stages Questionnaires (ASQ). Higher scores indicate better development. Domains include: (1) communication, (2) gross motor, (3) fine motor, (4) problem-solving, and (5) personal-social. |
1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Social Cognitive Attention Patterns - Sufficient Fixation Trials (number)
Délai: 6 months, 8 months, and 12 months of age.
|
Number of trials in which the fixation duration on specific Areas of Interest (social and non-social) exceeds 30% of the total fixation duration on the entire screen, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator indicates adequate attentional engagement with the presented social and non-social stimuli. |
6 months, 8 months, and 12 months of age.
|
|
Social Cognitive Attention Patterns - First Fixation Count (number)
Délai: 6 months, 8 months, 12 months of age.
|
Number of times the first fixation following stimuli onset lands on specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator captures initial attentional orienting and reflects the salience of the presented social and non-social stimuli. |
6 months, 8 months, 12 months of age.
|
|
Social Cognitive Attention Patterns - First Fixation Duration (seconds)
Délai: 6 months, 8 months, 12 months of age.
|
Duration (in seconds) of the first fixation within specific Areas of Interest (social and non-social) following stimulus onset, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects early-stage attentional processing and the efficiency of initial stimulus engagement. |
6 months, 8 months, 12 months of age.
|
|
Social Cognitive Attention Patterns - Total Fixation Count (number)
Délai: 6 months, 8 months, 12 months of age.
|
Total number of discrete fixation events occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects the overall frequency of attentional engagement with the presented social and non-social stimuli. |
6 months, 8 months, 12 months of age.
|
|
Social Cognitive Attention Patterns - Total Fixation Duration (seconds)
Délai: 6 months, 8 months, 12 months of age.
|
Cumulative duration (in seconds) of all fixations occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects overall attentional allocation to the presented social and non-social stimuli. |
6 months, 8 months, 12 months of age.
|
|
Social Cognitive Attention Patterns - Fixation Duration Proportion (%)
Délai: 6 months, 8 months, 12 months of age.
|
Percentage of total fixation time allocated to social or non-social Areas of Interest, calculated as (total fixation time on social or non-social Areas of Interest / total fixation time on all Areas of Interest) × 100, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects relative attentional preference between social and non-social stimuli. |
6 months, 8 months, 12 months of age.
|
|
Number of Participants with Physician-Diagnosed Allergic Diseases
Délai: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Number of participants who experience at least one episode of physician-diagnosed allergic diseases during the follow-up period, including eczema or atopic dermatitis, cow's milk protein allergy, other food allergies, allergic rhinitis, and asthma, as diagnosed by a physician and reported by parents, and confirmed by medical records. |
1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Li Cai, Ph.D, Sun Yat-sen University
- Chercheur principal: Lizi Lin, Ph.D, Sun Yat-sen University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
- Métabolomique
- Neurodéveloppement
- Cognition sociale
- Naissance prématurée
- Les acides gras
- Attention visuelle
- Oligosaccharides du lait maternel
- Naissance à terme
- Ostéopontine
- Croissance et développement de l'enfant
- Human Milk Composition
- Infant Gut Microbiome
- Human Milk Exposome
- Early-Life Nutrition
- Maternal Diet
Termes MeSH pertinents supplémentaires
- Maladies urogénitales
- Les troubles mentaux
- Troubles nutritionnels
- Maladies urogénitales féminines et complications de la grossesse
- Suralimentation
- Poids
- Travail obstétrique, prématuré
- Complications du travail obstétrical
- Complications de grossesse
- Conditions pathologiques, signes et symptômes
- Maladies nutritionnelles et métaboliques
- Signes et symptômes
- En surpoids
- Naissance prématurée
- Obésité
- Troubles neurodéveloppementaux
Autres numéros d'identification d'étude
- GPTBC
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .